Statutes, codes, and regulations
Missouri Administrative Code
Title 19 - DEPARTMENT OF HEALTH AND SENIOR SERVICESDivision 30 - Division of Regulation and Licensure
Chapter 1 - Controlled Substances
Section 19 CSR 30-1.002 - [Effective until 4/5/2025] Schedules of Controlled Substances

Mo. Code Regs. tit. 19 § 30-1.002

Download
PDF
Current through Register Vol. 49, No. 24, December 16, 2024
Section 19 CSR 30-1.002 - [Effective until 4/5/2025] Schedules of Controlled Substances

PURPOSE: The Department of Health and Senior Services has prepared a list of all drugs falling within the purview of controlled substances.

EMERGENCY STATEMENT: The United States Department of Justice Drug Enforcement Administration (DEA) continually evaluates substances to determine their clinical application and potential for abuse. Based on their evaluation, the DEA issues scheduling actions to place substances in the appropriate controlled substance schedules. The majority of these scheduling actions consist of temporarily and permanently scheduling newly-discovered illicit substances in Schedule I. Proper scheduling of these substances allow law enforcement to take action to prevent the further distribution of these substances. Scheduling substances in Schedules II-V allows practitioners to be informed about the potential for addiction/abuse of the substances and prescribe the substances appropriately. Section 195.015, RSMo charges the department with similarly controlling substances as they are controlled under federal law. Section 195.015.4 requires the Department of Health and Senior Services to submit emergency rules to the Secretary of State within thirty days of a federal scheduling action to allow for similar inclusion, rescheduling, or deletion of controlled substances with this schedule. While this time frame is difficult to achieve given the various approvals and reviews needed prior to the Department scheduling any rule with the Secretary of State, the Department still acts to effectuate these scheduling actions as quickly as possible. This emergency amendment includes all federal scheduling actions since the last amendment of this rule effective March 2204. This emergency amendment is necessary to protect Missouri's governmental interest in keeping its controlled substances schedules up-to-date as much as practically possible in order to protect its citizens and to aid law enforcement in its prosecution of those who illegally distribute these substances. As a result, the Department of Health and Senior Services finds a compelling governmental interest, which requires this emergency action. A proposed amendment, which covers the same material, is published in this issue of the Missouri Register. The scope of this emergency amendment is limited to the circumstances creating the emergency and complies with the protections extended in the Missouri and United States Constitutions. The Department of Health and Senior Services believes this emergency amendment is fair to all interested persons and parties under the circumstances. Subject to section 536.025, this emergency rule was filed September 24, 2024, becomes effective October 8, 2024, and expires April 5, 2025.

(1) Schedules of Controlled Substances.
(A) Schedule I shall consist of the drugs and other substances, by whatever official name, common or usual name, chemical name, or brand name designated, listed in this section. Each drug or substance has been assigned the Drug Enforcement Administration (DEA) Controlled Substances Code Number set forth opposite it.
1. Opiates. Unless specifically excepted or unless listed in another schedule, any of the following opiates, including their isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, whenever the existence of such isomers, esters, ethers, and salts is possible within the specific chemical designation:

A. Acetyl-alpha-methylfentanyl (N-(1-(1-methyl-2-phenethyl)-4-piperidinyl)-N-phenylacetamide)

9815

B. Acetylmethadol

9601

C. Acetyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide)

9821

D. N-(1-phenethylpiperidin-4-yl)-N-phenylacrylamide, its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers (other names: acryl fentanyl, acryloylfentanyl)

9811

E. AH-7921(3,4-dichloro-N-[(1-dimethylamino) cyclohexylmethyl] benzamide)

9551

F. Allylprodine

9602

G. Alphacetylmethadol (except levoalphacetylmethadol also known as levo-alpha-acetylmethadol levothadyl acetate or LAAM)

9603

H. Alphameprodine

9604

I. Alphamethadol

9605

J. alpha'-Methyl butyryl fentanyl (2-methyl-N-(1-phenethylpiperidin -4-yl)-N-phenylbutanamide)

9864

K. Alpha-methylfentanyl (N-1-(alphamethyl-beta-phenyl) ethyl-4-piperidyl) propionanilide; 1-(1-methyl-2-phenylethyl)-4 ((N-propanilido) piperidine)

9814

L. Alpha-methylthiofentanyl (N-(1-methyl-2-(2-thienyl) ethyl-4-piperidinyl)-N-phenylpropanamide)

9832

M. Benzethidine

9606

N. Betacetylmethadol

9607

O. Beta-hydroxyfentanyl (N-(1-(2-hydroxy-2-phenethyl)-4-piperidinyl)-N-phenylpropanamide)

9830

P. Beta-hydroxy-3-methylfentanyl (other name: N-(1-(2-hydroxy-2-phenethyl)-3-methyl-4-piperidinyl)-N-phenylpropanamide)

9831

Q. N-[1-[2-hydroxy-2-(thiophen- 2-yl) ethyl]piperidin-4-yl]- N-phenylpropionamide (other names: beta-hydroxythiofentanyl)

9836

R. Betameprodine

9608

S. Betamethadol

9609

T. beta-Methyl fentanyl (N-phenyl-N-(1-(2-phenylpropyl)piperidin-4-yl) propionamide (Other name: [BETA]-methyl fentanyl)

9856

U. beta'-Phenyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N,3-diphenylpropanamide (other names: [BETA]'-phenyl fentanyl; 3-phenylpropanoyl Fentanyl)

9842

V. Betaprodine

9611

W. Brorphine (1-(1-(1-(4-bromophenyl) ethyl)piperidin-4-yl)-1,3-dihydro-2H-benzo[d]imidazol-2-one)

9098

X. Butyryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylbutyramide)

9822

Y. Clonitazene

9612

Z. Crotonyl fentanyl ((E)-N-(1-phenethylpiperidin-4-yl)-N-phenylbut-2-enamide)

9844

AA. N-(1-phenethylpiperidin-4-yl)-N-Phenylcyclopentanecarboxamide (other name: cyclopentyl fentanyl)

9847

BB. Cyclopropyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylcyclopropanecarboxamide)

9845

CC. Dextromoramide

9613

DD. Diampromide

9615

EE. Diethylthiambutene

9616

FF. Difenoxin

9168

GG. Dimenoxadol

9617

HH. Dimepheptanol

9618

II. 2',5'-Dimethoxyfentanyl (N-(1-(2,5-dimethoxyphenethyl) piperidin-4-yl)-N-phenylpropionamide)

9861

JJ. Dimethylthiambutene

9619

KK. Dioxaphetyl butyrate

9621

LL. Dipipanone

9622

MM. Ethylmethylthiambutene

9623

NN. 2-(2-(4-ethoxybenzyl)-1H-benzimidazol-1-yl)-N, N-diethylethan-1-amine (other names: etodesnitazene; etazene)

9765

OO. Etonitazene

9624

PP. Etoxeridine

9625

QQ. Fentanyl carbamate (ethyl (1-phenethylpiperidin-4-yl) (phenyl)carbamate)

9851

RR. N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide, its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers (other names: 4-fluoroisobutyryl fentanyl, parafluoroisobutyryl fentanyl)

9824

SS. 2'-Fluoro orthofluorofentanyl (N-(1-(2-fluorophenethyl) piperidin-4-yl)-N-(2-fluorophenyl) propionamide (other names: 2'-fluoro 2-fluorofentanyl)

TT. N-(1-phenethylpiperidin-4-yl)-N-phenylfuran-2-carboxamide (other names: furanyl fentanyl)

9855

9834

UU. 3-Furanyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylfuran-3-carboxamide)

9860

VV. Furethidine

9626

WW. Hydroxypethidine

9627

XX. N-(1-phenethylpiperidin-4-yl)-N-phenylisobutyramide (other name: isobutyryl fentanyl)

9827

YY. Isotonitazene (N,N-diethyl-2-(2-(4-isopropoxybenzyl)-5-nitro-1H-benzimidazol-1-yl) ethan-1-amine)

9614

ZZ. Isovaleryl fentanyl (3-methyl-N-(1-phenethylpiperidin-4-yl)-N-phenylbutanamide)

9862

AAA. Ketobemidone

9628

BBB. Levomoramide

9629

CCC. Levophenacylmorphan

9631

DDD. meta-Fluorofentanyl (N-(3-fluorophenyl)-N-(1-phenethylpiperidin-4-yl) propionamide)

9857

EEE. meta-Fluoroisobutyryl fentanyl (N-(3-fluorophenyl)-N-(1-phenethylpiperidin-4-yl) isobutyramide)

9858

FFF. Methoxyacetyl fentanyl (2-methoxy-N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide

9825

GGG. 2-Methyl AP-237 (1-(2-methyl-4-(3-phenylprop-2-en-1-yl) piperazin-1-yl)butan-1-one)

9664

HHH. 4'-Methyl acetyl fentanyl (N-(1-(4-methylphenethyl) piperidin-4-yl)-N-phenylacetamide)

9819

III. 3-Methylfentanyl (N-(3-methyl-1-(2-phenylethyl)-4-piperidyl)-N-phenylproanamide), its optical and geometric isomers, salts, and salts of isomers

9813

JJJ. 3-Methylthiofentanyl (N-(3-methyl-1-(2-thienyl)ethyl-4-piperidinyl)-N-phenylpropanamide)

9833

KKK. Metonitazene (N,N-diethyl-2-(2-(4-methoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)ethan-1-amine)

-

9757

LLL. Morpheridine

9632

MMM. MPPP (1-methyl-4-phenyl-4-propionoxypiperidine)

9661

NNN. MT-45 (1-cyclohexyl-4-(1,2-diphenylethyl) piperazine)

(9560)

OOO. Noracymethadol

9633

PPP. Norlevorphanol

9634

QQQ. Normethadone

9635

RRR. Norpipanone

9636

SSS. 2-(4-ethoxybenzyl)-5-nitro-1-(2-(pyrrolidin-1-yl)ethyl)-1H-Benzimidazole (other names: N-pyrrolidino etonitazene; etonitazepyne)

9758

TTT. N-(2-fluorophenyl)-2-methoxy-N-(1-phenethylpiperidin-4-yl)acetamide, its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers (other name: ocfentanil)

9838

UUU. ortho-Fluoroacryl fentanyl (N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl) acrylamide)

9852

VVV. ortho-Fluorobutyryl fentanyl (N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl) butyramide (other name: 2-fluorobutyryl fentanyl)

9846

WWW. ortho-Fluorofentanyl (N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl) propionamide); other name: 2-fluorofentanyl)

9816

XXX. ortho-Fluorofuranyl fentanyl (N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl) furan-2-carboxamide)

9863

YYY. ortho-Fluoroisobutyryl fentanyl (N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide)

9853

ZZZ. ortho-Methyl acetylfentanyl (N-(2-methylphenyl)-N-(1-phenethylpiperidin-4-yl) acetamide (other name: 2-methyl acetylfentanyl)

9848

AAAA. ortho-Methyl methoxyacetyl fentanyl (2-methoxy-N-(2-methylphenyl)-N-(1-phenethylpiperidin-4-yl) acetamide (other name: 2-methyl methoxyacetyl fentanyl)

9820

BBBB. N-(4-chlorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide (other name: parachloroisobutyryl fentanyl)

9826

CCCC. para-Fluorobutyryl fentanyl (N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)butyramide)

9823

DDDD. para-Fluorofentanyl(N-(4-fluorophenyl)-N-(1-(2-phenethyl)-4-piperidinyl) propanamide

9812

EEEE. para-Fluoro furanyl fentanyl (N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)furan-2-carboxamide)

9854

FFFF. para-Methoxybutyryl fentanyl (N-(4-methoxyphenyl)-N-(1-phenethylpiperidin-4-yl) butyramide)

9837

GGGG. para-Methoxyfuranyl fentanyl (N-(4-methoxyphenyl)-N-(1-phenethylpiperidin-4-yl) furan-2-carboxamide

9859

HHHH. para-Methylcyclopropyl fentanyl (N-(4-methylphenyl) -N-(1-phenethylpiperidin-4-yl) cyclopropanecarboxamide)

9865

IIII. para-Methylfentanyl (N-(4-methylphenyl)-N-(1-phenethylpiperidin-4-yl) propionamide (other name: 4-methylfentanyl)

9817

JJJJ. PEPAP (1-(-2-phenethyl)-4-phenyl-4-acetoxypiperidine)

9663

KKKK. Phenadoxone

9637

LLLL. Phenampromide

9638

MMMM. Phenomorphan

9647

NNNN. Phenoperidine

9641

OOOO. Phenyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylbenzamide (other name: benzoyl fentanyl

) 9841

PPPP. Piritramide

9642

QQQQ. Proheptazine

9643

RRRR. Properidine

9644

SSSS. Propiram

9649

TTTT. N, N-diethyl-2-(5-nitro-2-(4-propoxybenzyl)-1H-benzimidazol-1-yl)ethan-1-amine (other name: Protonitazene)

9759

UUUU. Racemoramide

9645

VVVV. N-(1-phenethylpiperidin-4-yl)-N-phenyltetrahydrofuran-2-carboxamide, its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers (other name: tetrahydrofuranyl fentanyl)

9843

WWWW. Thiofentanyl (N-phenyl-N-(1-(2-thienyl)ethyl-4-piperidinyl)-propanamide

9835

XXXX. Thiofuranyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylthiophene-2-carboxamide (other names: 2-thiofuranyl fentanyl; thiophene fentanyl)

9839

YYYY. Tilidine

9750

ZZZZ. Trimeperidine

9646

AAAAA. U-47700 (3,4-Dichloro-N-[2-(dimethylamino) cyclohexyl]-N-methylbenzamide)

9547

BBBBB. N-(1-phenethylpiperidin-4-yl)-N-phenylpentanamide (other name: valeryl fentanyl)

9840

CCCCC. Zipeprol (1-methoxy-3-[4-(2-methoxy-2-phenylethyl) piperazin-1-yl]-1-phenylpropan-2-ol)

9873

2. Opium derivatives. Unless specifically excepted or unless listed in another schedule, any of the following opium derivatives, its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation:

A. Acetorphine

9319

B. Acetyldihydrocodeine

9051

C. Benzylmorphine

9052

D. Codeine methylbromide

9070

E. Codeine-N-Oxide

9053

F. Cyprenorphine

9054

G. Desomorphine

9055

H. Dihydromorphine

9145

I. Drotebanol

9335

J. Etorphine (except hydrochloride salt)

9056

K. Heroin

9200

L. Hydromorphinol

9301

M. Methyldesorphine

9302

N. Methyldihydromorphine

9304

O. Morphine methylbromide

9305

P. Morphine methylsulfonate

9306

Q. Morphine-N-Oxide

9307

R. Myrophine

9308

S. Nicocodeine

9309

T. Nicomorphine

9312

U. Normorphine

9313

V. Pholcodine

9314

W. Thebacon

9315

3. Hallucinogenic substances. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture or preparation, which contains any quantity of the following hallucinogenic substances or which contains any of its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation (For purposes of paragraph (1)(A)3. of this rule only, the term isomer includes the optical, position, and geometric isomers.):

A. Alpha-ethyltryptamine

7249

Some trade or other names: etryptamine; Monase; alpha-ethyl-1H-indole-3-ethenamine; 3-(2-aminobutyl)indole; alpha-ET; and AET;

B. 4-bromo-2,5-dimethoxyamphetamine

7391

Some trade or other names: 4-bromo-2, 5- dimethoxy-a- methylphenethylamine; 4-bromo- 2, 5-DMA;

C. 4-bromo-2,5-dimethoxyphenethylamine

7392

D. 2,5-dimethoxyamphetamine

7396

Some trade or other names: 2,5-dimethoxy- amethylphenethylamine; 2,5-DMA;

E. 2,5-dimethoxy-4-ethylamphetamine

7399

Some trade or other names: DOET;

F. 2,5-dimethoxy-4-(n)-propylthiophenethylamine (other name: 2C-T-7)

7348

G. 2-(2,5-Dimethoxy-4-(n)-propylphenyl) ethanamine (2C-P)

7524

H. 2-(2,5-Dimethoxy-4-ethylphenyl) ethanamine (2C-E)

7509

I. 2-(2,5-Dimethoxy-4-methylphenyl) ethanamine (2C-D)

7508

J. 2-(2,5-Dimethoxy-4-nitro-phenyl) ethanamine (2C-N)

7521

K. 2-(2,5-Dimethoxyphenyl) ethanamine (2C-H)

7517

L. 2-(4-Chloro-2,5-dimethoxyphenyl) ethanamine (2C-C)

7519

M. 2-(4-Ethylthio-2,5-dimethoxyphenyl) ethanamine (2C-T-2)

7385

N. 2-(4-Iodo-2,5-dimethoxyphenyl) ethanamine (2C-I)

7518

O. 2-(4-Isopropylthio)-2,5-dimethoxyphenyl) ethanamine (2C-T-4)

7532

P. 4-methoxyamphetamine

7411

Some trade or other names: 4-methoxy- amethylphenethylamine; paramethoxyamphetamine; PMA;

Q. 5-methoxy-3,4-methylenedioxyamphetamine

7401

R. 4-methyl-2,5-dimethoxyamphetamine

7395

Some trade and other names: 4-methyl-2, 5- dimethoxy-a- methylphenethylamine; DOM; and STP;

S. 3,4-methylenedioxyamphetamine

7400

T. 3,4-methylenedioxymetham-phetamine(MDMA)

7405

U. 3,4-methylenedioxy-N-ethylamphetamine (also known as N-ethylalpha-methyl-3,4 (methylenedioxy) phenethylamine, N-ethyl MDA, MDE, and MDEA)

7404

V. N-hydroxy-3,4-methylenedioxyamphetamine (also known as N-hydroxy-alpha-methyl-3,4 (methylenedioxy) phenethylamine and N-hydroxy MDA)

7402

W. 3,4,5-trimethoxyamphetamine

7390

X. 5-MeO-DMT or 5-methoxy-N,N-dimethyltryptamine

7431

Y. Alpha-methyltryptamine

7432

Z. Bufotenine

7433

Some trade and other names: 3-(b-Dimethylaminoethyl)- 5-hydroxyindole; 3-(2-dimethylaminoethyl)-5-indolol; N, N-dimethylserotonin; 5-hydroxy-N, N-dimethyltryptamine; mappine;

AA. Diethyltryptamine

7434

Some trade and other names: N, N-Diethyltryptamine; DET;

BB. Dimethyltryptamine

7435

Some trade or other names: DMT;

CC. 5-methoxy-N,N-diisopropyltryptamine (other name: 5-MeODIPT)

7439

DD. Ibogaine

7260

Some trade and other names: 7-Ethyl- 6,6[BETA],7,8,9,10,12,13- octahydro-2-methoxy-6, 9-methano-5H-pyrido [1',2':1,2] azepino[5,4-b] indole; Tabernanthe iboga;

EE. Lysergic acid diethylamide

7315

FF. Marihuana

7360

Some trade or other names: marijuana;

GG. Mescaline

7381

HH. Parahexyl

7374

Some trade or other names: 3-Hexyl-1- hydroxy-7,8,9,10- tetrahydro-6,6,9-trimethyl- 6H-dibenzo[b,d]pyran; Synhexyl;

II. Peyote

7415

Meaning all parts of the plant presently classified botanically as Lophophora williamsii Lemaire, whether growing or not; the seeds thereof; any extract from any part of such plant; and every compound, manufacture, salt, derivative, mixture, or preparation of such plant, its seeds, or extracts;

JJ. N-ethyl-3-piperidyl benzilate

7482

KK. N-methyl-3-piperidyl benzilate

7484

LL. Psilocybin

7437

MM. Psilocyn

7438

NN. Tetrahydrocannabinols naturally contained in a plant of the genus Cannabis (cannabis 7370 plant), as well as synthetic equivalents of the substances contained in the cannabis plant or in the resinous extractives of such plant, and/or synthetic substances, derivatives, and their isomers, or both, with similar chemical structure and pharmacological activity to those substances contained in the plant, such as the following:

(I) 1 cis or trans tetrahydrocannabinol and their optical isomers;

(II) 6 cis or trans tetrahydrocannabinol and their optical isomers;

(III) 3,4 cis or trans tetrahydrocannabinol and its optical isomers; and

(IV) Since nomenclature of these substances is not internationally standardized, compounds of these structures, regardless of numerical designation of atomic positions are covered;

OO. Ethylamine analog of phencyclidine

7455

Some trade or other names: N-ethyl-1- phenylcyclohexylamine, (1-phenylcyclohexyl) ethylamine, N-(1-phenylcyclohexyl)- ethylamine, cyclohexamine, PCE;

PP. Pyrrolidine analog of phencyclidine

7458

Some trade or other names: 1-(1-phenylcyclohexyl)-pyrrolidine PCPy, PHP;

QQ. Thiophene analog of phencyclidine

7470

Some trade or other names: 1-(1-(2-thienyl)- cyclohexyl)- piperidine, 2-thienyl analog of phencyclidine, TPCP, TCP;

RR. 1-(1-(2-thienyl)cyclohexyl) pyrrolidine

7473

Some other names: TCPy;

SS. Salvia divinorum

TT. Salvinorin A

UU. 3-Fluoromethcathinone

1233

VV. 4-Fluoromethcathinone

1238

WW. Mephedrone, or 4-methylmethcathinone

1248

XX. Methylenedioxypyrovalerone, MDPV, or (1-(1,3-Benzodioxol-5-yl)-2-(1-pyrrolidinyl)-1-pentanone

7535

YY. Methylone, or 3,4-Methylenedioxymethcathinone

7540

ZZ. Quinolin-8-yl 1-pentyl-1Hindole-3-carboxylate (PB-22; QUPIC)

7222

AAA. Quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate (5-fluoro-PB-22; 5F-PB-22)

7225

BBB. N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1Hindazole-3-carboxamide (AB-FUBINACA)

7012

CCC. N-(1-amino-3, 3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide (ADB-PINACA)

7035

DDD. (1-pentyl-1H-indol-3-yl) (2,2,3,3-tetramethylcyclopropyl) methanone (other names: UR-144, 1-pentyl-3-(2,2,3,3-tetramethylcyclopro-poyl)indole)

7144

EEE. [1-(5-fluoro-pentyl)-1Hindol-3-yl](2,2,3,3-tetramethylcyclopropyl) methanone (other names: 5-fluoro-UR-144, 5-F-UR-144, XLR11, 1-(5-fluo-ropentyl)-3-(2,2,3,3-tetramethylcyclopro-poyl)indole)

7011

FFF. N-(1-adamantyl)-1-pentyl-1Hindazole-3-carboxamide (other names: APINACA, AKB48)

7048

GGG. 2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine (other names: 251-NBOMe; 2C-I-NBOMe; 25I; Cimbi-5)

7538

HHH. 2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine (other names: 25C-NBOMe; 2C-C-NBOMe; 25C; Cimbi-82)

7537

III. 2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine (other names: 25B-NBOMe; 2C-B-NBOMe; 25B; Cimbi-36)

7536

JJJ. 4-methyl-N-ethylcathinone (other names: 4-MEC; 2-(ethylamino)-1-(4-methylphenyl)propan-1-one)

1249

KKK. 4-methyl-alphapyrrolid-inopropiophenone, (other names: 4-MePPP; MePPP; 4-methyl-[ALPHA]-pyrrolidinopropiophenone; 1-(4-methylphenyl)-2-(pyrrolidin-1-yl)-propan-1-one)

7498

LLL. alpha pyrrolidinopentio-phenone (other names: [ALPHA]-PVP; [ALPHA]-pyrrolidinovalerophenone; 1-phenyl-2-(pyrrolidin-1-yl)pentan-1-one)

7545

MMM. Butylone (other names: bk-MBDB; 1-(1,3-benzodioxol-5-yl)-2-(methylamino)butan-1-one)

7541

NNN. Pentedrone (other names: [ALPHA]- methylaminovalerophenone; 2-(methylamino)-1-phenylpentan-1-one)

1246

OOO. Pentylone (other names: bk-MBDP; 1-(1,3-benzodioxol-5-yl)-2-(methylamino)pentan-1-one)

7542

PPP. Naphyrone (other names: naphthylpyrovalerone; 1- (naphthalen-2-yl)-2-(pyrrolidin-1-yl)pentan-1-one)

1258

QQQ. alpha-pyrrolidinobutio-phenone (other names: [ALPHA]-PBP; 1-phenyl-2-(pyrrolidin-1-yl)butan-1-one)

7546

RRR. N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide (other names: AB-CHMINACA)

7031

SSS. N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1Hindazole-3-carboxamide (other names: AB-PINACA)

7023

TTT. [1-(5-fluoropentyl)- 1H-indazol-3-yl](naphthalen- 1-yl)methanone (other names: THJ-2201)

7024

UUU. N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide (other names: MAB-CHMINACA; ADB-CHMINACA)

7032

VVV. methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate (other names: 5F-ADB; 5F-MDMB-PINACA)

7034

WWW. methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3-methylbutanoate (other names: 5F-AMB)

7033

XXX. N-(adamantan-1-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide (other names: 5F-APINACA, 5F-AKB48)

7049

YYY. N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide (other names: ADB-FUBINACA)

7010

ZZZ. methyl 2-(1-(cyclohexylmethyl)-1H-indole-3-carboxamido)-3,3-dimethylbutanoate (other names: MDMB-CHMICA, MMB-CHMINACA)

7042

AAAA. methyl 2-(1-(4-fluorobenzyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate (other names: MDMB-FUBINACA)

7020

BBBB. methyl 2-(1-(4-fluorobenzyl)-1H-indazole-3-carboxamido)-3-methylbutanoate (other names: FUB-AMB, MMB- FUBINACA, AMB-FUBINACA)

(7021)

CCCC. 1-(1,3-benzodioxol-5-yl)-2-(ethylamino) propan-1-one (ethylone)

7547

DDDD. Naphthalen-1-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate (other names: NM2201; CBL2201)

7221

EEEE. N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide (other name: 5F-AB-PINACA)

7025

FFFF. 1-(4-cyanobutyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide (other names: 4-CN-CUMYLBUTINACA; 4-cyano-CUMYL-BUTINACA; 4-CN-CUMYLBINACA; CUMYL-4CNBINACA; SGT-78)

7089

GGGG. methyl 2-(1-(cyclohexylmethyl)-1H-indole-3-carboxamido)-3-methylbutanoate (other names: MMB-CHMICA; AMB-CHMICA)

7044

HHHH. 1-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)-1H-pyrrolo[2,3-b] pyridine-3-carboxamide (other name: 5F-CUMYL-P7AICA)

7085

IIII. N-ethylpentylone (other names: ephylone, 1-(1,3-benzodioxol-5-yl)-2-(ethylamino)-pentan-1-one)

7543

JJJJ. methyl 2-(1-(4-fluorobutyl)-1H-indazole-3-carboxamido)-3, 3-dimethylbutanoate (4F-MDMB-BINACA, 4F-MDMB-BUTINACA)

7043

KKKK. 1-(4-methoxyphenyl)-N-methylpropan-2-amine (other names: para-methoxymethamphetamine, PMMA)

1245

LLLL. ethyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate (other name: 5F-EDMB-PINACA)

7036

MMMM. methyl 2-(1-(5-fluoropentyl)-1H-indole-3-carboxamido)-3,3-Dimethylbutanoate (other names: 5F-MDMB-PICA; 5F-MDMB-2201)

7041

NNNN. N-(adamantan-1-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide (other names: FUB-AKB48; FUB-APINACA; AKB48 N-(4-FLUOROBENZYL))

7047

OOOO. 1-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide (other names: 5F-CUMYL-PINACA; SGT-25)

7083

PPPP. (1-(4-fluorobenzyl)-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl) methanone (other name: FUB-144)

7014

QQQQ. N-Ethylhexedrone (other names: [ALPHA]-ethylaminohexanophenone; 2-(ethylamino)-1-phenylhexan-1-one)

7246

RRRR. alpha-Pyrrolidinohexanophenone (other names: [ALPHA]-PHP; [ALPHA]-pyrrolidinohexanophenone; 1-phenyl-2-(pyrrolidin-1-yl)hexan-1-one)

7544

SSSS. 4-Methyl-alpha-ethylaminopentiophenonE (other names: 4-MEAP; 2-(ethylamino)-1-(4-methylphenyl)pentan-1-one)

7245

TTTT. 4'-Methyl-alpha-pyrrolidinohexiophenone (other names: MPHP; 4'-methyl- alpha-pyrrolidinohexanophenone; 1- (4-methylphenyl)-2-(pyrrolidin-1-yl)hexan- 1-one)

7446

UUUU. alpha-Pyrrolidinoheptaphenone (other names: PV8; 1-phenyl-2-(pyrrolidin-1-yl)heptan-1-one)

7548

VVVV. 4-Chloro-alpha-pyrrolidinovalerophenone (other names: 4-chloro-[ALPHA]-PVP; 4'-chloro-a- pyrrolidinopentiophenone; 1-(4- chlorophenyl)-2-(pyrrolidin-1-yl) pentan- 1-one)

7443

WWWW. 2-(ethylamino)-2-(3-methoxyphenyl)cyclohexan-1-one (methoxetamine, MXE)

7286

XXXX. 1-(1,3-benzodioxol-5-yl)-2-9 (ethylamino)butan-1-one (other names: eutylone; bk-EBDB)

7549

YYYY. N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-butyl-1H-indazole-3-carboxamide (other name: ADB-BUTINACA)

7027

ZZZZ. 4-methyl-1-phenyl-2-(pyrrolidin-1-yl)pentan-1-one (other names: [ALPHA]-PiHP; alpha-PiHP)

7551

AAAAA. 2-(methylamino)-1-(3-methylphenyl)propan-1-one (other names: 3-MMC; 3-methylmethcathinone)

1259

BBBBB. Synthetic cannabinoids: Unless specifically exempted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances, or which contains their salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation:

(I) Any compound structurally derived from 3-(1-naphthoyl)indole or 1Hindol-3-yl-(1-naphthyl)methane by substitution at the nitrogen atom of the indole ring by alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl or 2-(4-morpholinyl)ethyl group, whether or not further substituted in the indole ring to any extent, whether or not substituted in the naphthyl ring to any extent. Including, but not limited to:

(a) AM2201, or 1-(5-fluoropentyl)-3-(1-naphthoyl)indole

7201

(b) JWH-007, or 1-pentyl-2-methyl-3-(1-naphthoyl)indole

(c) JWH-015, or 1-propyl-2-methyl-3-(1-naphthoyl)indole

(d) JWH-018, or 1-pentyl-3-(1-naphthoyl)indole

7118

(e) JWH-019, or 1-hexyl-3-(1-naphthoyl)indole

7019

(f) JWH-073, or 1-butyl-3-(1-naphthoyl)indole

7173

(g) JWH-081, or 1-pentyl-3-(4-methoxy-1-naphthoyl)indole

7081

(h) JWH-098, or 1-pentyl-2-methyl-3-(4-methoxy-1-naphthoyl)indole

(i) JWH-122, or 1-pentyl-3-(4-methyl-1-naphthoyl)indole

7122

(j) JWH-164, or 1-pentyl-3-(7-methoxy-1-naphthoyl)indole

(k) JWH-200, or 1-(2-(4-(morpholinyl)ethyl) 3-(1-naphthoyl)indole

)7200

(l) JWH-210, or 1-pentyl-3-(4-ethyl-1-naphthoyl)indole

(m) JWH-398, or 1-pentyl-3-(4-chloro-1-naphthoyl)indole

7398

(II) Any compound structurally derived from 3-(1-naphthoyl)pyrrole by substitution at the nitrogen atom of the pyrrole ring by alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2- piperidinyl)methyl or 2-(4-morpholinyl)ethyl group, whether or not further substituted in the pyrrole ring to any extent, whether or not substituted in the naphthyl ring to any extent;

(III) Any compound structurally derived from 1-(1-naphthylmethyl)indene by substitution at the 3-position of the indene ring by alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2- piperidinyl)methyl or 2-(4-morpholinyl)ethyl group, whether or not further substituted in the indene ring to any extent, whether or not substituted in the naphthyl ring to any extent;

(IV) Any compound structurally derived from 3-phenylacetylindole by substitution at the nitrogen atom of the indole ring with alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2- piperidinyl) methyl or 2-(4-morpholinyl)ethyl group, whether or not further substituted in the indole ring to any extent, whether or not substituted in the phenyl ring to any extent. Including, but not limited to:

(a) JWH-201, or 1-pentyl-3-(4-methoxyphenylacetyl)indole

(b) JWH-203, or 1-pentyl-3-(2-chloropheny-lacetyl)indole

7203

(c) JWH-250, or 1-pentyl-3-(2-methoxypheny-lacetyl)indole

6250

(d) JWH-251, or 1-pentyl-3-(2-methylphenylacetyl)indole

(e) RCS-8, or 1-(2-cyclohexylethyl)-3-(2-methoxypheny-lacetyl)indole

7008

(V) Any compound structurally derived from 2-(3-hydroxycyclohexyl)phenol by substitution at the 5-position of the phenolic ring by alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl) methyl or 2-(4-morpholinyl)ethyl group, whether or not substituted in the cyclohexyl ring to any extent. Including, but not limited to:

(a) CP 47,497 and homologues, or 2-[(1R,3S)-3-hydroxycyclohexyl]-5-(2-methyloctan-2-yl)phenol), where side chain n=5, and homologues where side chain n-4, 6, or 7

7297, 7298

(VI) Any compound containing a 3- (benzoyl)indole structure with substitution at the nitrogen atom of the indole ring by alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl or 2-(4-morpholinyl)ethyl group, whether or not further substituted in the indole ring to any extent and whether or not substituted in the phenyl ring to any extent. Including, but not limited to:

(a) AM-694, or 1-(5-fluoropentyl)-3-(2-iodobenzoyl)indole

7694

(b) RCS-4, or 1-pentyl-3-(4-methoxybenzoyl)indole (SR-19 and RCS-4)

7104

(VII) CP 50,556-1, or [(6S,6aR,9R,10aR)-9-hydroxy-6-methyl-3-[(2R)-5-phenylpentan-2-yl]oxy-5,6,6a,7,8,9,10,10a-octahydrophenanthridin- 1-yl] acetate;

(VIII) HU-210, or (6aR,10aR)-9-(hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c] chromen-1-ol;

(IX) HU-211, or Dexanabinol,(6aS,10aS)-9-(hydroxymethyl)- 6,6-dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol;

(X) Dimethylheptylpyran, or DMHP.

4. Depressants. Unless specifically excepted or unless listed in another schedule, any material compound, mixture, or preparation which contains any quantity of the following substances having a depressant effect on the central nervous system, including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation:

A. Gamma-hydroxybutyric acid and other names GHB; gamma-hydroxybutyrate; 4-hydroxybutyrate; 4-hydroxybutonic acid; sodium oxybate; sodium oxybutryrate

;

2010

B. Mecloqualone

2572

C. Methaqualone

2565

5. Stimulants. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a stimulant effect on the central nervous system, including its salts, isomers, and salts of isomers:

A. Amineptine (7-[(10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5-yl)amino] heptanoic acid)

1219

B. Aminorex

Some trade or other names: aminoxaphen; 2-amino-5-phenyl-2-oxazoline; 4,5-dihydro-5-phenyl-2-oxazolamine;

1585

C. N-benzylpiperazine (some other names: BZP, 1-benzylpiperzaine)

7493

D. Cathinone (Some trade or other names: 2-amino-1-phenyl-1-propanone, alphaaminopropiophenone, 2-aminopropiophenone and norephedrone)

1235

E. 4,4'-Dimethylaminorex (4,4'-DMAR; 4,5-dihydro-4-methyl-5-(4-methylphenyl)-2-oxazolamine; 4-methyl-5-(4-methylphenyl)-4,5-dihydro-1,3-oxazol-2-amine)

1595

F. Fenethylline

1503

G. Mesocarb (N-phenyl-N'-(3-(1-phenylpropan-2-yl)-1,2,3-oxadiazol-3-ium-5-yl)carbamimidate)

1227

H. Methcathinone

Some trade or other names: 2-(methylamino)-propiophenone; alpha-(methylamino) propiophenone; 2-(methylamino)-1-phenylpropan-1-one; alpha-N-methylaminopropiophenone; monomethylpropion; ephedrone; N-methylcathinone; methylcathinine; AL-464; AL-422; AL-463 and URI 432;

1237

I. Methiopropamine (N-methyl-1-(thiophen-2-yl)propan-2-amine)

1478

J. 4-methoxymethcathinone

K. cis-4-methylaminorex (cis-4,5-dihydro-4-methyl-5-phenyl-2-oxazolamine)

1590

L. 4-Methyl-alpha-pyrrolidinobutiophenone, or MPBP

M. N-ethylamphetamine

1475

N. N,N-dimethylamphetamine

(some other names: N,N-alpha-trimethylbenzeneethanamine; N,N-alpha-trimethylphenethylamine)

1480

6. A temporary listing of substances subject to emergency scheduling under federal law shall include any material, compound, mixture, or preparation which contains any quantity of the following substances:

A. Fentanyl-related substances, their isomers, esters, ethers, salts, and salts of isomers, esters, and ethers.

9850

(I) Fentanyl-related substance means any substance not otherwise listed under another Administration Controlled Substance Code Number, and for which no exemption or approval is in effect under section 505 of the Federal Food, Drug, and Cosmetic Act 21 U.S.C. 355, that is structurally related to fentanyl by one (1) or more of the following modifications:

(a) Replacement of the phenyl portion of the phenethyl group by any monocycle, whether or not further substituted in or on the monocycle;

(b) Substitution in or on the phenethyl group with alkyl, alkenyl, alkoxyl, hydroxyl, halo, haloalkyl, amino, or nitro groups;

(c) Substitution in or on the piperidine ring with alkyl, alkenyl, alkoxyl, ester, ether, hydroxyl, halo, haloalkyl, amino, or nitro groups;

(d) Replacement of the aniline ring with any aromatic monocycle whether or not further substituted in or on the aromatic monocycle; and/or

(e) Replacement of the N-propionyl group by another acyl group.

B. 2-(2-(4-butoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)-N, N-diethylethan-1-amine, its isomers, esters, ethers, salts, and salts of isomers, esters and ethers (other name: Butonitazene)

9751

C. N, N-diethyl-2-(2-(4-fluorobenzyl)-5-nitro 1H-benzimidazol-1-yl)ethan-1-amine, its isomers, esters, ethers, salts, and salts of isomers, esters and ethers (other name: Flunitazene)

-

9756

D. N,N-diethyl-2-(2-(4-methoxybenzyl)-1H-benzimidazol-1-yl)ethan-1-amine, its isomers, esters, ethers, salts, and salts of isomers, esters and ethers (other name: Metodesnitazene)

9764

E. 4-(2-chlorophenyl)-2-ethyl-9- methyl-6H-thieno[3,2-f][1,2,4]triazolo [4,3-a][1,4]diazepine, its salts, isomers, and salts of isomers (other name: etizolam)

2780

F. 8-chloro-6-(2-fluorophenyl)-1- methyl-4H-benzo[f][1,2,4]triazolo [4,3-a][1,4]diazepine, its salts, isomers, and salts of isomers (other name: flualprazolam)

2785

G. 6-(2-chlorophenyl)-1-methyl-8- nitro-4H-benzo[f][1,2,4]triazolo [4,3-a][1,4]diazepine, its salts, isomers, and salts of isomers (other name: clonazolam)

2786

H. 8-bromo-6-(2-fluorophenyl)-1- methyl-4H-benzo[f][1,2,4]triazolo [4,3-a][1,4]diazepine, its salts, isomers, and salts of isomers (other name: flubromazolam)

2788

I. 7-chloro-5-(2-chlorophenyl)-1- methyl-1,3-dihydro-2Hbenzo [e][1,4]diazepin-2-one, its salts, isomers, and salts of isomers (other name: diclazepam)

2789

J. Methyl 3,3-dimethyl-2-(1-(pent-4-en-1-yl)-1H-indazole -3-carboxamido)butanoate, its optical and geometric isomers, salts and salts of isomers (other name: MDMB-4en-PINACA)

7090

K. Methyl 2-[[1-(4-fluorobutyl) indole-3-carbonyl]amino]-3,3 -dimethyl-butanoate, its optical and geometric isomers, salts and salts of isomers (other names: 4F-MDMB-BUTICA; 4F-MDMB-BICA)

7091

L. N-(1-Amino-3,3-dimethyl-1-oxobutan -2-yl)-1-(pent-4-en-1-yl)-1H-indazole -3-carboxamide, its optical and geometric isomers, salts and salts of isomers (other name: ADB-4en-PINACA)

7092

M. 5-Pentyl-2-(2-phenylpropan-2-yl)pyrido [4,3-b]indol-1-one, its optical and geometric isomers, salts and salts of isomers (other names: CUMYL-PEGACLONE; SGT-151)

7093

N. Ethyl 2-[[1-(5-fluoropentyl)indole-3 -carbonyl]amino]-3,3-dimethyl-butanoate, its optical and geometric isomers, salts and salts of isomers (other names: 5F-EDMB-PICA; 5F-EDMB-2201)

7094

O. Methyl 2-(1-(4-fluorobenzyl)-1H-indole-3-carboxamido)-3-methyl butanoate, its optical and geometric isomers, salts and salts of isomers (other name: MMB-FUBICA)

7095

P. N-ethyl-2-(2-(4-isopropoxybenzyl)-5- nitro-1H-benzimidazol-1-yl)ethan-1-amine, its isomers, esters, ethers, salts, and salts of isomers, esters and ethers (other name: N-desethyl isotonitazene)

9760

Q. 2-(4-ethoxybenzyl)-5-nitro-1-(2-(piperidin-1-yl)ethyl)-1H-benzimidazole, its isomers, esters, ethers, salts, and salts of isomers, esters and ethers (other names: N-piperidinyl etonitazene; etonitazepipne)

9761

7. Khat, to include all parts of the plant presently classified botanically as catha edulis, whether growing or not; the seeds thereof; any extract from any part of such plant; and every compound, manufacture, salt, derivative, mixture, or preparation of the plant, its seed, or extracts. 7032
(B) Schedule II shall consist of the drugs and other substances, by whatever official name, common or usual name, chemical name, or brand name designated, listed in this section. Each drug or substance has been assigned the Controlled Substances Code Number set forth opposite it.
1. Substances, vegetable origin, or chemical synthesis. Unless specifically excepted or unless listed in another schedule, Schedule II shall include any of the following substances whether produced directly or indirectly by extraction from substances of vegetable origin or independently by means of chemical synthesis or by a combination of extraction and chemical synthesis:
A. Opium and opiate; and any salt, compound, derivative, or preparation of opium or opiate, excluding apomorphine, thebaine-derived butorphanol, dextrorphan, nalbuphine, nalmefene, naloxegol, naloxone, and naltrexone and their respective salts, but including the following:

(I) Raw opium

9600

(II) Opium extracts

9610

(III) Opium fluid

9620

(IV) Powdered opium

9639

(V) Granulated opium

9640

(VI) Tincture of opium

9630

(VII) Codeine

9050

(VIII) Dihydroetorphine

9334

(IX) Ethylmorphine

9190

(X) Etorphine hydrochloride

9059

(XI) Hydrocodone

9193

(XII) Hydromorphone

9150

(XIII) Metopon

9260

(XIV) Morphine

9300

(XV) Oripavine

9330

(XVI) Oxycodone

9143

(XVII) Oxymorphone

9652

(XVIII) Thebaine

9333

B. Any salt, compound, derivative, or preparation thereof which is chemically equivalent or identical with any of the substances referred to in subparagraph (1)(B)1.A. of this rule shall be included in Schedule II, except that these substances shall not include the isoquinoline alkaloids of opium;
C. Opium poppy and poppy straw 9650
D. Coca leaves (9040) and any salt, compound, derivative, or preparation of coca leaves (including cocaine (9041) and ecgonine (9180) and their salts, isomers, derivatives, and salts of isomers and derivatives), and any salt, compound, derivative, or preparation thereof which is chemically equivalent or identical with any of these substances, except that the substances shall not include -
(I) Decocainized coca leaves or extraction of coca leaves, which extractions do not contain cocaine or ecgonine; or
(II) Ioflupane;
E. Concentrate of poppy straw (the crude extract of poppy straw in either liquid, solid, or powder form which contains the phenanthrene alkaloids of the opium poppy) 9670
2. Opiates. Unless specifically excepted or unless in another schedule any of the following opiates, including its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers whenever the existence of such isomers, esters, ethers, and salts is possible within the specific chemical designation, dextrorphan, and levopropoxyphene excepted:

A. Alfentanil

9737

B. Alphaprodine

9010

C. Anileridine

9020

D. Bezitramide

9800

E. Bulk Dextropropoxyphene (Non-dosage Forms)

9273

F. Carfentanil

9743

G. Dihydrocodeine

9120

H. Diphenoxylate

9170

I. Fentanyl

9801

J. Isomethadone

9226

K. Levo-alphacetylmethadol

Some other names: levo-alphaacetylmethadol, levomethadyl acetate, LAAM

9648

L. Levomethorphan

9210

M. Levorphanol

9220

N. Metazocine

9240

O. Methadone

9250

P. Methadone-Intermediate, 4-cyano-2-dimethylamino-4,4-diphenyl butane

9254

Q. Moramide-Intermediate, 2-methyl-3-morpholino-1, 1-diphenylpropane-carboxylic acid

9802

R. Oliceridine (N-[(3-methoxythiophen-2-yl) methyl] ({2-[(9R)-9-(pyridin-2-yl)-6-oxaspiro [4.5]decan-9-yl]ethyl})amine fumarate)

9245

S. Pethidine (Meperidine)

9230

T. Pethidine-Intermediate-A, 4-cyano-1-methyl-4-phenylpiperidine

9232

U. Pethidine-Intermediate-B, ethyl-4-phenylpiperidine-4-carboxylate

9233

V. Pethidine-Intermediate-C, 1-methyl-4-phenylpiperidine-4-carboxylic acid

9234

W. Phenazocine

9715

X. Piminodine

9730

Y. Racemethorphan

9732

Z. Racemorphan

9733

AA. Remifentanil

9739

BB. Sufentanil

9740

CC. Tapentadol

9780

DD. Thiafentanil

9729

3. Stimulants. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a stimulant effect on the central nervous system:

A. Amphetamine, its salts, optical isomers, and salts of its optical isomers

1100

B. Lisdexamfetamine, its salts, isomers, and salts of its isomers

1205

C. Methamphetamine, its salts, isomers, and salts of its isomers

1105

D. Phenmetrazine and its salts

1631

E. Methylphenidate

1724

4. Depressants. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a depressant effect on the central nervous system, including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation:

A. Amobarbital

2125

B. Glutethimide

2550

C. Pentobarbital

2270

D. Phencyclidine

7471

E. Secobarbital

2315

5. Hallucinogenic substances:

A. Nabilone

Another name for nabilone: (±)trans-3-(1, 1- dimethylheptyl)-6, 6a,7,8,10,10a-hexahydro- 1-hydroxy-6, 6-dimethyl-9H-dibenzo(b,d) pyran-9-one.

7379

B. Dronabinol (-)-delta-9-trans tetrahydrocannabinol in an oral solution in a drug product approved for marketing by the United States Food and Drug Administration.

(7365)

6. Immediate precursors. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances:

A. Immediate precursor to amphetamine and methamphetamine:

(I) Phenylacetone

8501

Some trade or other names: phenyl-2-propanone; P2P; benzyl methyl ketone; methyl benzyl ketone;

B. Immediate precursors to phencyclidine (PCP):

(I) 1-phenylcyclohexylamine

7460

(II) 1-piperidinocyclo-hexanecarbonitrile (PCC)

8603

C. Immediate precursor to fentanyl:

(I) 4-anilino-N-phenethyl-4-piperidine (ANPP)

8333

(II) N-phenyl-N-(piperidin-4-yl)propionamide (norfentanyl)

8366

7. Any material, compound, mixture, or preparation which contains any quantity of the following alkyl nitrites:
A. Amyl nitrite;
B. Butyl nitrite.
(C) Schedule III shall consist of the drugs and other substances, by whatever official name, common or usual name, chemical name, or brand name designated, listed in this section. Each drug or substance has been assigned the DEA Controlled Substances Code Number set forth opposite it.
1. Stimulants. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a stimulant effect on the central nervous system, including its salts, isomers (whether optical, position, or geometric), and salts of such isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation:

A. Those compounds, mixtures, or preparations in dosage unit form containing any stimulant substances listed in Schedule II which compounds, mixtures, or preparations were listed on August 25, 1971, as excepted compounds under 21 CFR 308.32 and any other drug of the quantitive composition shown in that list for those drugs or which is the same except that it contains a lesser quantity of controlled substances

1405

B. Benzphetamine

1228

C. Chlorphentermine

1645

D. Clortermine

1647

E. Phendimetrazine

1615

2. Depressants. Unless specifically excepted or unless listed in another schedule, any material compound, mixture, or preparation which contains any quantity of the following substances having a depressant effect on the central nervous system:

A. Any compound, mixture, or preparation containing -

(I) Amobarbital

2126

(II) Secobarbital

2316

(III) Pentobarbital

or any salt thereof and one (1) or more other active medicinal ingredients which are not listed in any schedule;

2271

B. Any suppository dosage form containing -

(I) Amobarbital

2126

(II) Secobarbital

2316

(III) Pentobarbital or any salt of any of these drugs and approved by the Food and Drug Administration for marketing only as a suppository;

2271

C. Any substance which contains any quantity of a derivative of barbituric acid or any salt thereof

2100

D. Chlorhexadol

2510

E. Embutramide

2020

F. Any drug product containing gamma hydroxybutyric acid, including its salts, isomers, and salts of isomer, for which an application is approved under section 505 of the Federal Food, Drug, and Cosmetic Act;

2012

G. Ketamine, its salts, isomer, and salts of isomers (some other names for ketamine: (±)-2-(2-chlorophenyl)-2-(methylamino)-cyclohexanone)

7285

H. Lysergic acid

7300

I. Lysergic acid amide

7310

J. Methyprylon

2575

K. Perampanel, and its salts, isomers, and salts of isomers

2261

L. Sulfondiethylmethane

2600

M. Sulfonethylmethane

2605

N. Sulfonmethane

2610

O. Tiletamine and zolazepam or any salt thereof

Some trade or other names for a tiletaminezolazepam combination product: Telazol.

Some trade or other names for tiletamine: 2- (ethylamino)-2-(2-thienyl)-cyclohexanone.

Some trade or other names for zolazepam: 4-(2-fluorophenyl)-6-8-dihydro-1,3,8- trimethylpyrazolo-(3,4-e) (1,4)-diazepin-7(1H)-one, flupyrazapon.

7295

3. Nalorphine 9400
4. Narcotics drugs. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation containing limited quantities of any of the following narcotic drugs or any salts thereof:

A. Not more than one and eight tenths grams (1.8gm) of codeine per one hundred milliliters (100 mL) or not more than ninety milligrams (90 mg) per dosage unit, with an equal or greater quantity of an isoquinoline alkaloid of opium

9803

B. Not more than one and eight tenths grams (1.8gm) of codeine per one hundred milliliters (100 mL) or not more than ninety milligrams (90 mg) per dosage unit, with one (1) or more active, nonnarcotic ingredients in recognized therapeutic amounts

9804

C. Not more than one and eight tenths grams (1.8gm) of dihydrocodeine per one hundred milliliters (100 mL) or not more than ninety milligrams (90 mg) per dosage unit, with one (1) or more active, nonnarcotic ingredients in recognized therapeutic amounts

9807

D. Not more than three hundred milligrams (300 mg) of ethylmorphine per one hundred milliliters (100 mL) or not more than fifteen milligrams (15 mg) per dosage unit, with one (1) or more active, nonnarcotic ingredients in recognized therapeutic amounts

9808

E. Not more than five hundred milligrams (500 mg) of opium per one hundred milliliters (100 mL) or per one hundred grams (100 gm) or not more than twenty-five milligrams (25 mg) per dosage unit, with one (1) or more active nonnarcotic ingredients in recognized therapeutic amounts

9809

F. Not more than fifty milligrams (50 mg) of morphine per one hundred milliliters (100 mL) or per one hundred grams (100 gm), with one (1) or more active, nonnarcotic ingredients in recognized therapeutic amounts

9810

5. Any material, compound, mixture, or preparation containing any of the following narcotic drugs or their salts, as set forth below:

A. Buprenorphine

9064

6. Anabolic steroids. Unless specifically excepted or unless listed in another schedule, any substance meeting the definition of anabolic steroid as set forth in 21 CFR 1300.01, of the August 1, 2023, Code of Federal Regulations, as published by the Office of the Federal Register, National Archives and Records Administration, 700 Pennsylvania Avenue, Washington, DC 20408, which is hereby incorporated by reference and does not include later amendments or additions, including any material, compound, mixture or preparation containing any quantity of the following substances, including its salts, esters, and ethers (4000):
A. 5[ALPHA]-androstan-3,17-dione;
B. 5[ALPHA]-androstan-3,6,17-trione;
C. 1-androstenediol (3[BETA],17[BETA]-dihydroxy-5[ALPHA]-androst-1-ene);
D. 1-androstenediol (3[ALPHA],17[BETA]-dihydroxy-5[ALPHA]-androst-1-ene);
E. 4-androstenediol (3[BETA],17[BETA]-dihydroxy-androst-4-ene);
F. 5-androstenediol (3[BETA],17[BETA]-dihydroxy-androst-5-ene);
G. 1-androstenedione (5[ALPHA]-androst-1-en-3,17-dione);
H. 4-androstenedione (androst-4-en-3,17-dione);
I. 5-androstenedione (androst-5-en-3,17-dione);
J. bolasterone (7[ALPHA],17[ALPHA]-dimethyl-17[BETA]-hydroxyandrost-4-en-3-one);
K. boldenone (17[BETA]-hydroxyandrost-1,4-diene-3-one);
L. boldione (androsta-1,4-diene-3,17-dione);
M. 6-bromo-androsta-1,4-diene-3,17-dione;
N. 6-bromo-androstan-3,17-dione;
O. calusterone (7[BETA],17[ALPHA]-dimethyl-17[BETA]-hydroxyandrost-4-en-3-one);
P. 4-chloro-17[ALPHA]-methyl-androsta-1,4-diene-3,17[BETA]-diol;
Q. 4-chloro-17[ALPHA]-methyl-androst-4-ene-3[BETA],17[BETA]-diol;
R. 4-chloro-17[ALPHA]-methyl-17[BETA]-hydroxy-androst-4-en-3-one;
S. 4-chloro-17[ALPHA]-methyl-17[BETA]-hydroxy-androst-4-ene-3,11-dione;
T. clostebol (4-chloro-17[BETA]-hydroxy-androst-4-en-3-one);
U. dehydrochloromethyltestosterone (4-chloro-17[BETA]-hydroxy-17[ALPHA]-methyl-androst-1,4-dien-3-one);
V. desoxymethyltestosterone (17[ALPHA]-methyl-5[ALPHA]-androst-2-en-17[BETA]-ol) (a.k.a. "madol");
W. 4-dihydrotestosterone (17[BETA]-hydroxy-androstan-3-one);
X. [DELTA]1-dihydrotestosterone (a.k.a. "1-testosterone") (17[BETA]-hydroxy-5[ALPHA]-androst-1-en-3-one);
Y. 3[BETA],17[BETA]-dihydroxy-5[ALPHA]-androstane;
Z. 3[ALPHA],17[BETA]-dihydroxy-5[ALPHA]-androstane;
AA. 2[ALPHA],17[ALPHA]-dimethyl-17[BETA]-hydroxy-5[BETA]-androstan-3-one;
BB. drostanolone (17[BETA]-hydroxy-2[ALPHA]-methyl-5[ALPHA]-androstan-3-one);
CC. 2[ALPHA],3[ALPHA]-epithio-17[ALPHA]-methyl-5[ALPHA]-androstan-17[BETA]-ol;
DD. estra-4,9,11-triene-3,17-dione;
EE. 13[BETA]-ethyl-17[BETA]-hydroxygon-4-en-3-one;
FF. ethylestrenol (17[ALPHA]-ethyl-17[BETA]-hydroxyestr-4-ene);
GG. fluoxymesterone (9-fluoro-17[ALPHA]-methyl-11[BETA],17[BETA]-dihydroxyandrost-4-en-3-one);
HH. formebolone (2-formyl-17[ALPHA]-methyl-11[ALPHA],17[BETA]-dihydroxyandrost-1,4-dien-3-one);
II. furazabol (17[ALPHA]-methyl-17[BETA]-hydroxyandrostano[2,3-c] furazan);
JJ. [3,2-c]furazan-5[ALPHA]-androstan-17[BETA]-ol;
KK. 18a-homo-3-hydroxy-estra-2,5(10)-dien-17-one;
LL. 4-hydroxy-19-nortestosterone (4,17[BETA]-dihydroxy-estr-4-en-3-one);
MM. 4-hydroxy-androst-4-ene-3,17-dione;
NN. 17[BETA]-hydroxy-androstano[2,3-d]isoxazole;
OO. 17[BETA]-hydroxy-androstano[3,2-c]isoxazole;
PP. 3[BETA]-hydroxy-estra-4,9,11-trien-17-one;
QQ. 4-hydroxytestosterone (4,17[BETA]-dihydroxy-androst-4-en-3-one);
RR. mestanolone (17[ALPHA]-methyl-17[BETA]-hydroxy-5[ALPHA]-androstan-3-one);
SS. mesterolone (1[ALPHA]-methyl-17[BETA]-hydroxy-5[ALPHA]-androstan-3-one);
TT. methandienone (17[ALPHA]-methyl-17[BETA]-hydroxyandrost-1,4-dien-3-one);
UU. methandriol (17[ALPHA]-methyl-3[BETA],17[BETA]-dihydroxyandrost-5-ene);
VV. methasterone (2[ALPHA],17[ALPHA]-dimethyl-5[ALPHA]-androstan-17[BETA]-ol-3-one or 2[ALPHA],17[ALPHA]-dimethyl-17[BETA]-hydroxy-5[ALPHA]-androstan-3-one);
WW. methenolone (1-methyl-17[BETA]-hydroxy-5[ALPHA]-androst-1-en-3-one);
XX. 17[ALPHA]-methyl-androsta-1,4-diene-3,17[BETA]-diol;
YY. 17[ALPHA]-methyl-5[ALPHA]-androstan-17[BETA]-ol;
ZZ. 17[ALPHA]-methyl-androstan-3-hydroxyimine-17[BETA]-ol;
AAA. 6[ALPHA]-methyl-androst-4-ene-3,17-dione;
BBB. 17[ALPHA]-methyl-androst-2-ene-3,17[BETA]-diol;
CCC. 17[ALPHA]-methyl-3[BETA],17[BETA]-dihydroxy-5[ALPHA]-androstane;
DDD. 17[ALPHA]-methyl-3[ALPHA],17[BETA]-dihydroxy-5[ALPHA]-androstane;
EEE. 17[ALPHA]-methyl-3[BETA],17[BETA]-dihydroxyandrost-4-ene;
FFF. 17[ALPHA]-methyl-4-hydroxynandrolone (17[ALPHA]-methyl-4-hydroxy-17[BETA]-hydroxyestr-4-en-3-one);
GGG. methyldienolone (17[ALPHA]-methyl-17[BETA]-hydroxyestra-4,9(10)-dien-3-one);
HHH. 17[ALPHA]-methyl-[DELTA]1-dihydrotestosterone (17[BETA]-hydroxy-17[ALPHA]-methyl-5[ALPHA]-androst-1-en-3-one) (a.k.a. "17-[ALPHA]-methyl-1-testosterone");
III. methyltestosterone (17[ALPHA]-methyl-17[BETA]-hydroxyandrost-4-en-3-one);
JJJ. methyltrienolone (17[ALPHA]-methyl-17[BETA]-hydroxyestra-4,9,11-trien-3-one);
KKK. mibolerone (7[ALPHA],17[ALPHA]-dimethyl-17[BETA]-hydroxyestr-4-en-3-one);
LLL. nandrolone (17[BETA]-hydroxyestr-4-en-3-one);
MMM. 19-nor-4-androstenediol (3[BETA],17[BETA]-dihydroxyestr-4-ene);
NNN. 19-nor-4-androstenediol (3[ALPHA],17[BETA]-dihydroxyestr-4-ene);
OOO. 19-nor-5-androstenediol (3[BETA],17[BETA]-dihydroxyestr-5-ene);
PPP. 19-nor-5-androstenediol (3[ALPHA],17[BETA]-dihydroxyestr-5-ene);
QQQ. 19-nor-4,9(10)-androstadienedione (estra-4,9(10)-diene-3,17-dione);
RRR. 19-nor-4-androstenedione (estr-4-en-3,17-dione);
SSS. 19-nor-5-androstenedione (estr-5-en-3,17-dione);
TTT. norbolethone (13[BETA],17[ALPHA]-diethyl-17[BETA]-hydroxygon-4-en-3-one);
UUU. norclostebol (4-chloro-17[BETA]-hydroxyestr-4-en-3-one);
VVV. norethandrolone (17[ALPHA]-ethyl-17[BETA]-hydroxyestr-4-en-3-one);
WWW. normethandrolone (17[ALPHA]-methyl-17[BETA]-hydroxyestr-4-en-3-one);
XXX. oxandrolone (17[ALPHA]-methyl-17[BETA]-hydroxy-2-oxa-5[ALPHA]-androstan-3-one);
YYY. oxymesterone (17[ALPHA]-methyl-4,17[BETA]-dihydroxyandrost-4-en-3-one);
ZZZ. oxymetholone (17[ALPHA]-methyl-2-hydroxymethylene-17[BETA]-hydroxy-5[ALPHA]-androstan-3-one);
AAAA. prostanozol (17[BETA]-hydroxy-5[ALPHA]-androstano[3,2-c] pyrazole or [3,2-c]pyrazole-5[ALPHA]-androstan-17[BETA]-ol);
BBBB. [3,2-c]pyrazole-androst-4-en-17[BETA]-ol;
CCCC. stanozolol (17[ALPHA]-methyl-17[BETA]-hydroxy-5[ALPHA]-androst-2-eno[3,2-c]-pyrazole);
DDDD. stenbolone (17[BETA]-hydroxy-2-methyl-5[ALPHA]-androst-1-en-3-one);
EEEE. testolactone (13-hydroxy-3-oxo-13,17-secoandrosta-1,4-dien-17-oic acid lactone);
FFFF. testosterone (17[BETA]-hydroxyandrost-4-en-3-one);
GGGG. tetrahydrogestrinone (13[BETA],17[ALPHA]-diethyl-17[BETA]- hydroxygon-4,9,11-trien-3-one); and
HHHH. trenbolone (17[BETA]-hydroxyestr-4,9,11-trien-3-one).
7. Dronabinol (synthetic) in sesame oil and encapsulated in a soft gelatin capsule in a United States Food and Drug Administration approved drug product 7369

(Some other names for dronabinol: (6[ALPHA]Rtrans)-6a,7,8,10[ALPHA]-tetrahydro-6.6.9-trimethyl-3-pentyl-6H-dibenzo (b,d) pyran-1-ol, or (-) -delta-9-(trans)-tetrahydrocannabinol.)

(D) Schedule IV shall consist of the drugs and other substances, by whatever official name, common or usual name, chemical name, or brand name designated, listed in this subsection. Each drug or substance has been assigned the DEA Controlled Substances Code Number set forth opposite it.
1. Narcotic drugs. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation containing limited quantities of any of the following narcotic drugs or any salts thereof:
A. Not more than one milligram (1 mg) of difenoxin (DEA Drug Code No. 9168) and not less than twenty-five micrograms (25 mcg) of atropine sulfate per dosage unit 9167
B. Dextropropoxyphene (alpha-(+)-4-dimethylamino-1,2-diphenyl-3-methyl-2-propionoxybutane) 9278
C. 2-[(dimethylamino)methyl]-1-(3-methoxyphenyl) cyclohexanol, its salts, optical and geometric isomers, and salts of these isomers (including tramadol) 9752
D. Narcotic drugs containing nonnarcotic active medicinal ingredients. Any compound, mixture, or preparation containing any of the following limited quantities of narcotic drugs or salts thereof, which shall include one (1) or more nonnarcotic active medicinal ingredients in sufficient proportion to confer upon the compound, mixture, or preparation valuable medicinal qualities other than those possessed by the narcotic drug alone:
(I) Not more than two hundred milligrams (200 mg) of codeine per one hundred milliliters (100 mL) or per one hundred grams (100 gm);
(II) Not more than one hundred milligrams (100 mg) of dihydrocodeine per one hundred milliliters (100 mL) or per one hundred grams (100 gm); or
(III) Not more than one hundred milligrams (100 mg) of ethylmorphine per one hundred milliliters (100 mL) or per one hundred grams (100 gm).
2. Depressants. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances, including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation:

A. Alfaxalone

2731

B. Alprazolam

2882

C. Barbital

2145

D. Brexanolone

2400

E. Bromazepam

2748

F. Camazepam

2749

G. Carisoprodol

8192

H. Chloral betaine

2460

I. Chloral hydrate

2465

J. Chlordiazepoxide

2744

K. Clobazam

2751

L. Clonazepam

2737

M. Clorazepate

2768

N. Clotiazepam

2752

O. Cloxazolam

2753

P. Daridorexant

2410

Q. Delorazepam

2754

R. Diazepam

2765

S. Dichloralphenazone

2467

T. Estazolam

2756

U. Ethchlorvynol

2540

V. Ethinamate

2545

W. Ethyl loflazepate

2758

X. Fludiazepam

2759

Y. Flunitrazepam

2763

Z. Flurazepam

2767

AA. Fospropofol

2138

BB. Halazepam

2762

CC. Haloxazolam

2771

DD. Ketazolam

2772

EE. Lemborexant

2245

FF. Loprazolam

2773

GG. Lorazepam

2885

HH. Lormetazepam

2774

II. Mebutamate

2800

JJ. Medazepam

2836

KK. Meprobamate

2820

LL. Methohexital

2264

MM. Methylphenobarbital (Mephobarbital)

2250

NN. Midazolam

2884

OO. Nimetazepam

2837

PP. Nitrazepam

2834

QQ. Nordiazepam

2838

RR. Oxazepam

2835

SS. Oxazolam

2839

TT. Paraldehyde

2585

UU. Petrichloral

2591

VV. Phenobarbital

2285

WW. Pinazepam

2883

XX. Prazepam

2764

YY. Quazepam

2881

ZZ. Remimazolam

2846

AAA. Suvorexant

2223

BBB. Temazepam

2925

CCC. Tetrazepam

2886

DDD. Triazolam

2887

EEE. Zaleplon

2781

FFF. Zolpidem

2783

GGG. Zopiclone

2784

HHH. Zuranolone

2420

3. Lorcaserin. Any material, compound, mixture, or preparation which contains any quantity of the following substances, including its salts, isomers, and salts of isomers, whenever the existence of such salts, isomers, and salts of isomers is possible:

A. Lorcaserin

1625

4. Stimulants. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a stimulant effect on the central nervous system, including its salts, isomers, and salts of isomers:

A. Cathine ((+)-norpseudoephedrine)

1230

B. Diethylpropion

1610

C. Fencamfamin

1760

D. Fenproporex

1575

E. Mazindol

1605

F. Mefenorex

1580

G. Modafinil

1680

H. Pemoline (including organometallic complexes and chelates thereof)

1530

I. Phentermine

1640

J. Pipradrol

1750

K. Serdexmethylphenidate

1729

L. Sibutramine

1675

M. Solriamfetol (2-amino-3-phenylpropyl carbamate; benzenepropanol, betaamino-, carbamate (ester))

1650

N. SPA (-)-1-dimethylamino-1,2-diphenylethane

1635

5. Other substances. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances, including its salts:

A. Pentazocine

9709

B. Butorphanol (including its optical isomers)

9720

C. Eluxadoline (5-[[[(2S)-2-amino-3-[4- aminocarbonyl)-2,6-dimethylphenyl]-1-oxopropyl] [(1S)-1-(4-phenyl-1 H-imidazol-2-yl) ethyl]amino]methyl]-2-methoxybenzoic acid) (including its optical isomers) and its salts, isomers, and salts of isomers

l)

d)

9725

6. Ephedrine. Any material, compound, mixture, or preparation which contains any quantity of the following substances having a stimulant effect on the central nervous system including their salts, isomers, and salts of isomers:
A. Ephedrine or its salts, optical isomers, or salts of optical isomers as the only active medicinal ingredient or contains ephedrine or its salts, optical isomers, or salts of optical isomers and therapeutically insignificant quantities of another active medicinal ingredient.
(E) Schedule V shall consist of the drugs and other substances, by whatever official name, common or usual name, chemical name, or brand name designated, listed in this subsection.
1. Narcotic drugs containing nonnarcotic active medicinal ingredients. Any compound, mixture, or preparation containing any of the following narcotic drugs, or their salts calculated as the free anhydrous base or alkaloid, in limited quantities as follows, which shall include one (1) or more nonnarcotic active medicinal ingredients in sufficient proportion to confer upon the compound, mixture, or preparation valuable medicinal qualities other than those possessed by the narcotic drug alone:
A. Not more than one hundred milligrams (100 mg) of dihydrocodeine per one hundred milliliters (100 mL) or per one hundred grams (100 gm);
B. Not more than one hundred milligrams (100 mg) of ethylmorphine per one hundred milliliters (100 mL) or per one hundred grams (100 gm);
C. Not more than two and five-tenths milligrams (2.5 mg) of diphenoxylate and not less than twenty-five micrograms (25 mcg) of atropine sulfate per dosage unit;
D. Not more than one hundred milligrams (100 mg) of opium per one hundred milliliters (100 mL) or per one hundred grams (100 gm); and
E. Not more than five-tenths milligram (0.5 mg) of difenoxin (DEA Drug Code No. 9168) and not less than twenty-five micrograms (25 mcg) of atropine sulfate per dosage unit.
2. Stimulants. Unless specifically exempted or excluded or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a stimulant effect on the central nervous system including its salts, isomers, and salts of isomers:

A. Pyrovalerone

1485

3. Any compound, mixture, or preparation containing any detectable quantity of pseudoephedrine or its salts or optical isomers, or salts of optical isomers or any compound, mixture, or preparation containing any detectable quantity of ephedrine or its salts or optical isomers, or salts of optical isomers if the drug preparations are starch-based solid dose forms, if such preparations are sold over the counter without a prescription. The following drug preparations containing ephedrine and pseudoephedrine are not scheduled controlled substances:
A. Drug preparations in liquid form; and
B. Drug preparations that require a prescription in order to be dispensed.
4. Unless specifically exempted or excluded or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a depressant effect on the central nervous system, including its salts:

A. Ezogabine [N-[2-amino-4(4-fluorobenzylamino)-phenyl]-carbamic acid ethyl ester]

2779

B. Ganaxolone (3[ALPHA]-hydroxy-3[BETA]-methyl-5[ALPHA]-pregnan-20-one)

2401

C. Lacosamide [(R)-2-acetoamido-N-benzyl-3-methoxy-propionamide]

2746

D. Pregabalin [(S)-3-(aminomethyl)-5-methylhexanoic acid]

2782

E. Brivaracetam ((25)-2-[(4R)-2-oxo-4-propylpyrrolidin-1-yl]butanamide) (also referred to as BRV; UCB-34714; Briviact)

2710

F. Lasmiditan [2,4,6-trifluoro-N-(6-(1-methylpiperidine-4-carbonyl) pyridine-2-yl-benzamide]

2790

G. Cenobamate ([(1R)-1-(2-chlorophenyl)-2-(tetrazol-2-yl)ethyl] carbamate; 2H-tetrazole-2-ethanol, alpha-(2-chlorophenyl)-, carbamate (ester), (alphaR)-; carbamic acid (R)-(+)-1-(2-chlorophenyl)-2-(2H-tetrazol-2-yl)ethyl ester)

2720

19 CSR 30-1.002

AUTHORITY: sections 195.015 and 195.195, RSMo 2000.* Material found in this rule previously filed as 19 CSR 30-1.010. Original rule filed April 14, 2000, effective Nov. 30, 2000. Amended: Filed Jan. 31, 2003, effective July 30, 2003.
Amended by Missouri Register April 3, 2017/Volume 42, Number 07, effective 5/31/2017
Amended by Missouri Register March 15, 2019/Volume 44, Number 6, effective 4/30/2019
Amended by Missouri Register March 15, 2021/Volume 46, Number 06, effective 4/30/2021
Amended by Missouri Register November 1, 2021/Volume 46, Number 21, effective 10/13/2021
Amended by Missouri Register February 15, 2022/Volume 47, Number 4, effective 3/31/2022
Amended by Missouri Register February 1, 2023/Volume 48, Number 3, effective 3/31/2023
Amended by Missouri Register November 1, 2023/volume 48, Number 21, effective 10/10/2023, exp. 4/6/2024 (Emergency)
Amended by Missouri Register February 15, 2024/volume 49, Number 04, effective 3/31/2024.
Amended by Missouri Register November 5, 2024/volume 49, Number 21, effective 10/8/2024, exp. 4/5/2025 (Emergency).